Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML

NCT05477589 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

170

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Myeloid Leukemia (AML) in Remission
Stem Cell Transplantation

Interventions

DRUG: busulfan, cyclophosphamide and melphalan, BuCyMel
DRUG: clofarabine, fludarabine and busulfan, CloFluBu

Sponsor

Vastra Gotaland Region